Difference between revisions of "23andme"
Jump to navigation
Jump to search
Tags: Mobile web edit, Mobile edit |
|||
(14 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
− | [[wikipedia:23andme]] ([[2006]]) | + | [[wikipedia:23andme]] ([[2006]], [[Nasdaq]] 2021) |
− | [[ | + | * [[Anne Wojcicki]] |
− | [[Sergey Brin]] | + | * [[Sergey Brin]] |
+ | * [[Linda Avey]] | ||
+ | |||
+ | 23andMe formed a partnership with the drug giant GlaxoSmithKline to discover new drugs using data culled from millions of the company’s customers | ||
+ | |||
+ | == Related terms == | ||
+ | * [[GlaxoSmithKline]] | ||
+ | * [[Virgin Group]] | ||
+ | * [[Fidelity Management & Research Company LLC]] | ||
+ | * [[Altimeter Capital]] | ||
+ | * [[Casdin Capital]] | ||
+ | * [[Foresite Capital]] | ||
+ | * [[Lemonaid]] | ||
+ | * [[Ancestry.com]] | ||
+ | * [[Nucleus Genomics]] | ||
+ | * [[Sequencing.com]] | ||
== See also == | == See also == | ||
* {{DNA}} | * {{DNA}} | ||
+ | |||
+ | [[Category:Genetics]] |
Latest revision as of 20:04, 13 April 2023
wikipedia:23andme (2006, Nasdaq 2021)
23andMe formed a partnership with the drug giant GlaxoSmithKline to discover new drugs using data culled from millions of the company’s customers
Related terms[edit]
- GlaxoSmithKline
- Virgin Group
- Fidelity Management & Research Company LLC
- Altimeter Capital
- Casdin Capital
- Foresite Capital
- Lemonaid
- Ancestry.com
- Nucleus Genomics
- Sequencing.com
See also[edit]
Advertising: